SciMar ONE is a startup focused on accelerating drug development with AI. Founded in 2021 and headquartered in the United States, the company leverages its proprietary AI-powered solution, the DV Platform™, to enable the pharmaceutical industry to move promising therapies from the lab to the market faster. With a focus on AI, Data Analytics, Health Care, Information Technology, and the Pharmaceutical sector, SciMar ONE aims to revolutionize drug development using cutting-edge technologies. Currently, there is no publicly disclosed information about their last investment or the investors involved in their latest funding round.
General Information
BounceWatch is an independent company data service, not affiliated with SciMar ONE. To contact SciMar ONE, visit scimarone.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
About SciMar ONE
Taxonomy: AI-powered solution, pharmaceutical industry, drug development, DV Platform™, Development Velocity, Clinical Data, Data Mining, Cloud-based, Drug Development Acceleration, Therapies, Pharma, Data Visualization
No funding data available for SciMar ONE yet.
SciMar ONE Alternatives & Competitors
Applying machine learning in drug development
Through our data and technology solutions, we transform data into actionable insights, and streamlin...
Matching research sites to the right clinical trial protocols, unlocking site potential worldwide.
FAQ About SciMar ONE
Source: BounceWatch company record for SciMar ONE, https://bouncewatch.com/company/scimar-one, updated 2 January 2025. When citing, please name BounceWatch and link this page.